From: Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer
Variable | n | Survivin- | Survivin+ | χ2 | p | VEGF-C - | VEGF-C + | χ2 | p |
---|---|---|---|---|---|---|---|---|---|
Age | Â | Â | Â | 0 | 1 | Â | Â | 0.965 | 0.326 |
≤45 years | 36 | 6 | 30 |  |  | 6 | 30 |  |  |
>45 years | 72 | 12 | 60 |  |  | 18 | 54 |  |  |
Tumor size | Â | Â | Â | 9.305 | 0.01 | Â | Â | 4.102 | 0.129 |
T1 | 39 | 12 | 27 | Â | Â | 12 | 27 | Â | Â |
T2 | 60 | 6 | 54 | Â | Â | 9 | 51 | Â | Â |
T3 | 9 | 0 | 9 | Â | Â | 3 | 6 | Â | Â |
Histological grade | Â | Â | Â | 0.873 | 0.350 | Â | Â | 0.175 | 0.675 |
I + II | 99 | 15 | 84 |  |  | 21 | 78 |  |  |
III | 9 | 3 | 6 | Â | Â | 3 | 6 | Â | Â |
Pathological style | Â | Â | Â | 0.169 | 0.681 | Â | Â | 0 | 1 |
ISC | 12 | 3 | 9 | Â | Â | 3 | 9 | Â | Â |
IC | 96 | 15 | 81 | Â | Â | 21 | 75 | Â | Â |
Lymph node metastasis | Â | Â | Â | 16.283 | 0.000 | Â | Â | 18.544 | 0.000 |
Negative | 30 | 12 | 18 | Â | Â | 15 | 15 | Â | Â |
Positive | 78 | 6 | 72 | Â | Â | 9 | 69 | Â | Â |
C-erBb-2 | Â | Â | Â | 8.269 | 0.004 | Â | Â | 4.354 | 0.037 |
positive(3 + ) | 12 | 6 | 6 |  |  | 6 | 6 |  |  |
negative(0-2 + ) | 96 | 12 | 84 |  |  | 18 | 78 |  |  |
ER | Â | Â | Â | 0.617 | 0.432 | Â | Â | 0.882 | 0.348 |
positive | 63 | 9 | 54 | Â | Â | 12 | 51 | Â | Â |
negative | 45 | 9 | 36 | Â | Â | 12 | 33 | Â | Â |
PR | Â | Â | Â | 0 | 1 | Â | Â | 1.929 | 0.165 |
positive | 54 | 9 | 45 | Â | Â | 15 | 39 | Â | Â |
negative | 54 | 9 | 45 | Â | Â | 9 | 45 | Â | Â |
TNM stage | Â | Â | Â | 10.800 | 0.001 | Â | Â | 6.027 | 0.014 |
I, II | 72 | 18 | 54 | Â | Â | 21 | 51 | Â | Â |
III, IV | 36 | 0 | 36 | Â | Â | 3 | 33 | Â | Â |